DeCure's autonomous Rare AI scientist is researching a drug-repurposing hypothesis for female reproductive system disease — screening already-approved drugs against its 23-gene Open Targets disease module to publish open-access research. Research is fast; the path to publication is funded in milestone stages.
Disease moduleFemale reproductive system disease maps to a 23-gene Open Targets module — the target space DeCure's AI scientist screens approved drugs against.
DeCure.ai methodSignature reversal (LINCS) plus network proximity (STRING) rank already-approved drugs likely to perturb this module — the same engine that produces DeCure.ai's repurposing hypotheses.
Repurposing thesisScreening approved medicines against this disease module, then publishing the evidence for the strongest candidate. Known pharmacology and human exposure data make the first question sharper — they do not establish safety or efficacy in a new indication.
Research record
01
ResearchComing soon
Candidate research + dossier — target rationale, drug-repurposing thesis and evidence pack.proof: Published dossier + on-chain hash
02
ValidationComing soon
In-vitro biological validation at a contract research org (CRO).proof: CRO contract + in-vitro report
03
Peer review & paperComing soon
Peer-reviewed paper published open-access (preprint + journal).proof: DOI + open-access link + on-chain hash
Current lead
No approved-drug candidate for female reproductive system disease is corroborated in the literature DeepSearch retrieved. Some conditions are managed with non-pharmacological care — a device, surgery or physical therapy — rather than a medicine; that may be the case here, or the literature we found may simply be too sparse yet to support a drug-repurposing angle.
Molecular view
spectrin repeat containing nuclear envelope protein 1 (SYNE1) — SYNE1 is one of the genes genetically linked to this disease in Open Targets — shown as context, not as a drug target we're pursuing: no approved-drug candidate for this disease is yet corroborated in the literature we found.
Loading structure…
helix sheet pgedrag to rotate · scroll to zoom
RCSB Protein Data Bank · entry 6R15 · 1.82 Å · ligand TRIETHYLENE GLYCOL (PGE). Experimental structure, not a prediction.
What the evidence adds up to
In a study of 24 female childhood cancer survivors from the Royal Hospital for Sick Children in Edinburgh, perceived stress was inversely associated with ovarian function, while biomarkers of hypothalamic-pituitary-adrenal activity were positively associated with ovarian function. The authors used the Perceived Stress Scale, salivary and hair cortisol measures, and serum gonadotropin and anti-Müllerian hormone levels. No drug was tested or mentioned.
A theoretical review of combined diseases of the female reproductive system—uterus, ovaries, mammary glands—notes that modern understanding of their etiopathogenesis and diagnostic algorithms remains incomplete. The authors argue that fuller information would allow more thoughtful treatment, but no specific drug, trial, or outcome data are provided.
A separate overview describes malformations of the female genital system—ovaries, ductal system, external genitalia—and states that evaluation requires imaging and chromosomal studies. No treatment or drug is discussed.
A journal summary of reproductive immunology states the field studies interactions between reproductive tissues and the immune system, and claims to offer solutions for infertility, recurrent miscarriage, reproductive cancers, fibroids, and pregnancy complications. No concrete data, sample sizes, or drug names are given.
Evidence
Retrieved by DeepSearch across 234,678,978 indexed works and resolved on OpenAlex — ranked by citations, including the results that did not work.
Oncology nursing forum · 2019 · 4 citations
Chronic Stress and Ovarian Function in Female Childhood Cancer Survivors
AbstractOBJECTIVES: To explore the relationships among perceived stress, biomarkers of hypothalamic-pituitary-adrenal (HPA) activity, gonadotropin levels, and anti-Müllerian hormone (AMH) in female childhood cancer survivors (CCSs). SAMPLE & SETTING: 24 female CCSs from the Royal Hospital for Sick Children in Edinburgh, Scotland, were included in the study. METHODS & VARIABLES: Perceived stress was measured using the Perceived Stress Scale. HPA activity was measured using salivary cortisol and hair cortisol. Ovarian function was measured using serum gonadotropin levels and serum AMH levels. Latent growth curve modeling was used to determine diurnal cortisol slope and intercept. Bayesian structural equation modeling was used to explore the relationship among perceived stress, biomarkers of HPA activity, and ovarian function. RESULTS: The authors found an inverse association between perceived stress and ovarian function and a positive association between biomarkers of HPA activity and ovarian function. IMPLICATIONS FOR NURSING: Further research is needed to understand factors contributing to risk for post-treatment reproductive dysfunction in female CCSs.
Reports of Vinnytsia National Medical University · 2019 · 4 citations · open access
The problem of combined diseases in the reproductive system of the women
AbstractAnnotation. This article highlights the urgent problem of combined diseases of women's reproductive system. On the basis of theoretical analysis, generalized statistics for recent years are presented. The modern concepts of pathogenesis of diseases of the uterus and mammary glands, their correlation, as well as models of diagnosis and treatment are considered. Indeed, a more in-depth understanding of the problems of the combined pathology of the woman’s reproductive system (diseases of the uterus, ovaries, mammary gland), namely etiopathogenesis, diagnostic and treatment algorithms, will reduce the incidence of women of reproductive and perimenopausal age, as well as improve their quality of life. Only having the fullness of information about the state of the reproductive system of women, the doctor is able to prescribe thoughtful and effective treatment.
Oxford University Press eBooks · 2015 · 1 citations
Female Genital System
AbstractAbstract The female genital system comprises the ovaries, the ductal system, and external genitalia. Malformations of this system may interfere with female hormone production, fertility and childbearing, development of secondary sexual characteristics, and appearance of the external genitalia. Evaluation requires imaging of the internal sexual structures and studies to determine chromosomal sex, as well as other studies to determine the cause.
Reproductive Immunology Open Access · 2016 · 0 citations · open access
Cellular and Molecular Mechanisms in Reproductive Immunology
AbstractReproductive immunology is a field of medicine which studies the interactions between reproductive tissues and the immune system. It offers solutions to various reproductive disorders associated with immune dysfunctions, such as infertility problems of men and women, recurrent miscarriages, cancers of reproductive tissues, fibroids, and various pregnancy complications. Reproductive Immunology: Open Access (RIOA) is an international, peer-reviewed, journal that publishes new articles in all the related topics of reproductive immunology. The main goal of the journal is to provide a forum for researchers and clinicians to disseminate new research findings and concepts related to the field of reproductive immunobiology. Here, we highlight several novel findings recently published in RIOA.
Journal of obstetrics and women s diseases · 1999 · 0 citations · open access
Infections and reproductive health (Part I)
AbstractInfectious and inflammatory diseases of female genitals occupy a special place in structure of general morbidity on a planet. Their importance is caused first of all by the fact, that these illnesses involve organs and tissues concerning to reproductive system, and consequently have direct influence on reproductive function and continuation of a life in the world. In the first part of this clinical lecture ther are considered and are stated in details the modern aspects of a reproductive health problem.
Disease module: DeepOracle (Open Targets). Structures: RDKit from PubChem SMILES. Literature: retrieved by DeepSearch across 234,678,978 indexed works (targeted per-candidate search), resolved on OpenAlex.
DeCure is a research and publication project, not medical advice and not a treatment. "DeCure for X" describes a research goal, not a claim that a cure exists. Backing a cure is a contribution to fund the research — it is not an investment, and confers no yield, royalty, equity or IP ownership. Papers are published open-access by the DeCure.ai DAO.
